Alvotech shares fall 2.34% premarket despite reporting strong H1 2025 earnings and product revenue growth.

Alvotech declined 2.34% in premarket trading, despite reporting strong financial results for the first six months of 2025, including over 200% growth in product revenues year-on-year and a best quarter in terms of operating cash flows. The company also announced continued expansion of commercial partnerships for pipeline assets and its listing on the Nasdaq Stockholm Market.